Compare RICK & VRXA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | RICK | VRXA |
|---|---|---|
| Founded | 1983 | 2021 |
| Country | United States | Germany |
| Employees | N/A | N/A |
| Industry | Restaurants | Biotechnology: Pharmaceutical Preparations |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 214.6M | 199.4M |
| IPO Year | 1996 | 2025 |
| Metric | RICK | VRXA |
|---|---|---|
| Price | $25.67 | $1.13 |
| Analyst Decision | | |
| Analyst Count | 0 | 0 |
| Target Price | N/A | N/A |
| AVG Volume (30 Days) | 31.4K | ★ 230.2K |
| Earning Date | 08-06-2026 | N/A |
| Dividend Yield | ★ 1.22% | N/A |
| EPS Growth | N/A | N/A |
| EPS | ★ 0.16 | N/A |
| Revenue | ★ $144,896,000.00 | N/A |
| Revenue This Year | $16.98 | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | $163.44 | ★ N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $20.76 | $1.04 |
| 52 Week High | $32.00 | $4.50 |
| Indicator | RICK | VRXA |
|---|---|---|
| Relative Strength Index (RSI) | 35.70 | 37.47 |
| Support Level | $25.23 | $1.04 |
| Resistance Level | $26.83 | $1.41 |
| Average True Range (ATR) | 0.71 | 0.13 |
| MACD | -0.04 | 0.01 |
| Stochastic Oscillator | 5.97 | 19.00 |
RCI Hospitality Holdings Inc through its subsidiaries, owns and operates establishments that offer live adult entertainment, restaurant, and or bar operations. It also owns and operates a communication company serving the adult nightclub industry. The company's operating business segments are Nightclubs, Bombshells, and Others. It operates nightclubs through the following brands Rick's Cabaret, Vivid Cabaret, Tootsie's Cabaret, Club Onyx, and Jaguars Club. In the Bombshells segment, the company is building a chain of Restaurants and Sports Bars in Dallas, Austin, and Houston, Texas. It derives the majority of revenue from the Nightclubs segment that engages in the sale of alcoholic beverages, food, and merchandise items; service in the form of cover charges, and room rentals.
Veraxa Biotech Holding AG focus on antibody therapies in medicine. The Company is an oncology-focused biotechnology Company with a clinical program in acute myeloid leukemia and two proprietary platform technologies that enable the development of new generations of antibody drug conjugates (ADC's) and T cell engagers. The Company operates in one reportable segment, focused on the research and development of products for the aging population.